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Abstract
Background: Headache disorders, particularly migraine and tension-type headache (TTH), are among the most
prevalent global public-health problems. Medication-overuse headache (MOH) is a common sequela of
mismanagement of these. Migraine and MOH are highly disabling. Formulation of responsive health policy requires
reliable, locally-derived, population-based data describing both individual and societal impact of headache
disorders. South-East Asia is the only one of WHO’s six world regions in which no such national data have yet been
gathered.
Methods: In a nationwide population-based cross-sectional study, a representative sample of Nepalese-speaking
adults (18–65 years) were randomly selected by stratified multistage cluster sampling. Trained interviewers made
unannounced door-to-door visits and enquired into headache and its attributable burden using a culturally-
adapted and validated Nepalese translation of the Headache-Attributed Restriction, Disability, Social Handicap and
Impaired Participation (HARDSHIP) questionnaire.
Results: Among 2100 participants, 1794 (85.4 %) reported headache during the preceding year (male: 689 [38.4 %],
female 1105 [61.6 %]; mean age 36.1 ± 12.6 years). Mean headache frequency was 3.8 ± 6.2 days/month, mean
headache intensity 2.1 ± 0.7 on a 0–3 scale, and mean attack duration 41.9 ± 108.5 h. All aspects of symptom burden
(frequency, intensity and duration) were greater among females (p < 0.001). Participants with headache had poorer
quality of life (QoL) than those without (p < 0.001); QoL was worst among those with probable MOH (pMOH).
Mean proportions of total available time spent in the ictal state were 5.4 % among participants with migraine, 3.9 %
among those with TTH and 44.7 % among those with pMOH, with headache-related disabilities of 2.4, 0.15 and 9.7 %
respectively. At population level, these disorders were responsible for reduced functional capacities of 0.81, 0.06 and
0.20 %. Total lost productive time due to headache was 6.8 % for the 85 % of the population with headache. Males lost
more paid worktime than females (p < 0.001); the reverse was so for household worktime (p < 0.001).
Conclusions: Headache disorders, very common in Nepal, are also highly burdensome at both individual and
population levels. There is a substantial penalty in lost production. The remedy lies in better health care for headache;
structured headache-care services are urgently needed in the country, and likely to be cost-saving.
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Background
Primary headache disorders – migraine and tension-type
headache (TTH) – are among the most prevalent diseases
in the world [1–3]. These disorders, together with their
major sequela, medication-overuse headache (MOH), are
of substantial importance to public health nationally and
globally because they lead to widespread ill health and
impaired quality of life (QoL) and are disabling [4] The
Global Burden of Disease Study 2013 (GBD2013) found
migraine to be the sixth highest cause of disability world-
wide, and MOH the 18th, measured in years of life lost to
disability (YLDs) [3]. Collectively, headache disorders are
the third highest cause of disability in the world [5]. The
economic consequences through productivity losses are
substantial [6].
Mitigating action is required, a message strongly en-
dorsed by the World Health Organization (WHO) [4, 7].
But decisions about the allocation of national health-care
resources are best informed by reliable, locally-derived,
population-based data. This is especially important in
developing countries such as Nepal, which have very con-
strained health budgets and a clear imperative to maxi-
mise health gain from them. In the case of headache care,
this means data on the burden attributable to headache
disorders harvested from the population of Nepal as the
basis of needs assessment. Recent population-based stud-
ies in other developing countries [8–10] have shown high
headache prevalences and heavy headache-attributable
burden, but these factors remain poorly described in many
large and populous areas of the world [2, 4] – nowhere
more obviously than in the South-East Asia Region
(SEAR). In fact, SEAR, in which Nepal lies, is the only one
of WHO’s six world regions for which no national data of
this type have yet been gathered in any country [4].
Nepal is one of the poorest countries within SEAR
[11], but with great geographic and cultural diversity. Its
location in the Himalayas, and their foothills and plains
beyond, includes eight of the world’s ten highest peaks,
among them Mount Everest, the highest point on Earth
[11]. Its population is approximately 30 million [12],
with a rather unequal distribution of wealth so that
about one quarter live below the international poverty
line [11]. The majority of Nepalese engage in agriculture
[13]. More than 70 ethnic groups maintain different cul-
tures and spoken languages [13].
We earlier reported headache prevalence data from
our adult population-based study in Nepal [14]. The 1-
year prevalence of migraine in this country (34.1 %) was
uniquely high, while the point prevalence of probable
MOH (pMOH) (2.1 %) was towards the upper end of
the range for most countries studied [15]. The 1-year
prevalence of TTH (44.1 %) was in line with the global
average [2, 3]. Here, with the specific purpose of inform-
ing health policy, and as a study conducted within the
Global Campaign against Headache, we report the esti-
mates of burden attributable to these disorders in Nepal.
Methods
Ethics
The Nepal Health Research Council, the Institutional
Review Committee of Kathmandu University School of
Medical Sciences, Dhulikhel Hospital, and the Regional
Committee for Health and Research Ethics in Central
Norway all approved the study protocol.
All participants were informed about the nature and
purpose of the study and this was documented in ac-
cordance with requirements of the three committees.
Study design and sampling
The study design, sampling and data collection procedures
have been reported in detail previously [16]. In summary,
this was a cross-sectional survey using structured inter-
views administered by trained health workers making un-
announced door-to-door visits during May, 2013. To
obtain a nationally representative sample, we used multi-
stage stratified cluster sampling in all three physiographic
divisions of the country and, within each division, all five
development regions (Far-Western, Midwestern, Western,
Central and Eastern). We randomly selected one eligible
adult (aged 18–65 years, Nepalese-speaking and living in
Nepal) from each household.
Instruments
We used the Headache-Attributed Restriction, Disability,
Social Handicap and Impaired Participation (HARDSHIP)
questionnaire developed by Lifting The Burden (LTB) for
population-based studies [17]. The original English-
language version was translated into Nepalese according
to LTB’s translation protocol for hybrid documents [18]
and modified according to Nepalese culture [19]. The
questionnaire consisted of four parts relevant to this re-
port. For all participants there were (i) personal and
demographic enquiry and (ii) a neutral headache screen-
ing question (“Have you had a headache during the last
12 months?”). Those who answered “no” to the latter were
classified as headache-free. Those who answered “yes”
were asked whether their headaches were of one or more
types and, if more than one, to focus only on the most
bothersome type. Only those who answered positively to
the screening question were also asked (iii) diagnostic
questions in line with the International Classification of
Headache Disorders (ICHD-3 beta) [20], and (iv) ques-
tions ascertaining various aspects of headache burden.
We measured symptom burden in terms of frequency
(days/month), intensity (with response options “not bad”,
“quite bad” and “very bad”, which we interpreted as mild,
moderate and severe) and duration (hours).
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We enquired into willingness to pay (WTP) as an
overall measure of burden [17] using a bidding game
method [21]. We asked how much participants would be
willing to pay per month for an effective treatment such
that their headaches would no longer bother them. Bid-
ding began at NPR 100/month (at the time of the survey,
NPR 100 ≈USD 1): was the respondent willing to pay
this amount? If “yes”, the interviewer incremented the
bidding stepwise (NPR 200, 400, 1000 and 2000) until
the answer was “no”, or it was clear that the participant
would pay > NPR 2000. If the opening bid of NPR 100
was declined, the interviewer instead reduced stepwise
(NPR 40 and 20) until the participant said “yes”, or it be-
came clear that nothing would be paid. Finally, in every
case, an exact amount was agreed upon as the individ-
ual’s WTP-value.
We assessed QoL using the World Health Organization
Quality of Life-8 (WHOQOL-8) questionnaire [22]. Its
eight items addressed subjective wellbeing and satisfaction
in four domains (two in each): psychological, physical, so-
cial and environmental [17]. Each item was graded on a
scale of 1–5, with a higher score indicating better QoL.
We estimated lost time due to headache during the pre-
ceding 3 months using the Headache-Attributed Lost
Time (HALT) questionnaire [23]. Its first two questions
asked for the numbers of days in that period (i) completely
missed from paid work and (ii) with <50 % productivity
because of headache while at work; the next two asked for
numbers of days of household work (iii) completely
missed and (iv) with <50 % productivity; the last enquired
into (v) the number of days on which family, social or
leisure activities were missed because of headache.
Headache diagnosis
The diagnostic method has been described previously [14].
Diagnoses were not made during the interviews but later
according to an algorithm. Participants reporting headache
on ≥15 days/month were first separated as a distinct group
because they cannot be fully diagnosed by questionnaire.
Those who in addition were overusing acute medication
were considered to have pMOH [24]; the remainder were
categorised as “other headache on ≥15 days/month”. To all
others, reporting headache on ≤14 days/month, the algo-
rithm applied modified ICHD-3 beta criteria [20] in the fol-
lowing order: definite migraine, definite TTH, probable
migraine and probable TTH. Definite and probable mi-
graine were subsequently considered together, and likewise
definite and probable TTH, for attribution of burden. The
few remaining cases were unclassifiable.
Statistics
Categorical variables are presented as numbers and per-
centages. Continuous variables are presented as means
with standard deviations (SDs) and/or medians with
interquartile ranges (IQRs).
We transformed the categorical variable for headache
intensity (mild, moderate, and severe) into a numerical
scale 0–3 (0 being no pain), and treated these results as
continuous data.
We summed responses to the first four items (i-iv) of
HALT to estimate total productivity loss. These scores
were treated as continuous variables. We separately
summed the first and second items (i, ii) to estimate lost
paid worktime, and the third and fourth (iii, iv) to esti-
mate lost household worktime.
We estimated individual and population-level disability
attributable to migraine, TTH and pMOH using the dis-
ability weights (DWs) from GBD2013 [3] for the ictal
states of each. We calculated the mean absolute time
spent in the ictal state (Tabs) as the product of mean at-
tack frequency (AF) and mean attack duration (D). For
migraine, because headache frequency (HF) had been re-
corded as days/month, we assumed participants with at-
tacks lasting >24 h had counted days affected rather
than number of attacks per month. Therefore, to calcu-
late mean AF we made separate computations for those
with attack durations of ≥24 h and <24 h, using the for-
mula AF =HF/D in the former group. We then took the
weighted mean of the two groups. We did not need to
perform the same manipulation for TTH, because the
mean duration of headache was <24 h (Table 1). For
pMOH, we made separate calculations for those describ-
ing durations of <24 h and those asserting pain “never
goes away”, for whom we assumed AF = 30 and D = 24;
there were no respondents in between. Again we took
the weighted mean. From Tabs (in hours/year) we calcu-
lated the proportion of total available time that was
spent in the ictal state (Tpro) by dividing by (24*365).
We multiplied this proportion by the DW for the
disorder in question to calculate individual disability
(DISper), and then by the prevalence of the disorder to
arrive at population-level disability (DISpop).
We used Student’s t-test for significance of differences
between means of two groups and one-way analysis of
variance (ANOVA) for more than two groups. Since
most of the continuous variables were skewed in distri-
bution, we also used the non-parametric Mann–Whitney
U-test or Kruskal-Wallis test to examine differences be-
tween groups. We considered p < 0.05 as statistically sig-
nificant. All data were analysed with SPSS 21.0 software
(SPSS Inc., Chicago, IL, USA).
Results
We interviewed 2100 participants aged 18–65 years
(participation rate >99 % [16]), of whom 1794 (85.4 %) re-
ported headache during the preceding year (male: 689
[38.4 %], female 1105 [61.6 %]; mean age 36.1 ± 12.6 years;
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Table 1 Symptom burden: frequency, intensity and duration of headache for all headache and each headache type, by gender
All Male Female pa
All headache (N = 1794 [males 689; females 1105])
Headache frequency (days/month)
Mean ± SD 3.8 ± 6.2 2.9 ± 4.8 4.3 ± 6.9 <0.001
Median [IQR] 2.0 [0.4–3.0] 1.0 [0.3–3.0] 2.0 [0.5–4.0] <0.001
Headache intensity
Not bad 373 (20.8) 184 (26.7) 189 (17.1)
Quite bad 901 (50.2) 344 (49.9) 557 (50.4)
Very bad 520 (29.0) 161 (23.4) 359 (32.5)
Meanb ± SD 2.1 ± 0.7 2.0 ± 0.7 2.2 ± 0.7 <0.001
Medianb [IQR] 2 [2, 3] 2 [1, 2] 2 [2, 3] <0.001
Headache duration (hours)
Mean ± SD 41.9 ± 108.5 23.3 ± 46.8 53.4 ± 131.9 <0.001
Median [IQR] 8.0 [2.0–45.0] 6.0 [1.3–24.0] 10.0 [2.3–48.0] <0.001
Migraine (N = 728 [males 249; females 479])
Headache frequency (days/month)
Mean ± SD 2.3 ± 0.6 2.2 ± 2.3 2.4 ± 2.3 0.46
Median [IQR] 2.0 [0.4–3.0] 2.0 [0.3–3.0] 2.4 [0.6–3.0] 0.29
Headache intensity
Not bad 60 (8.2) 21 (8.4) 39 (8.1)
Quite bad 354 (48.6) 123 (49.4) 231 (48.2)
Very bad 314 (43.1) 105 (42.2) 209 (43.6)
Meanb ± SD 2.3 ± 0.6 2.2 ± 0.6 2.4 ± 0.6 0.72
Medianb [IQR] 2 [2, 3] 2 [2, 3] 2 [2, 3] 0.71
Headache duration
Mean ± SD 33.6 ± 47.9 29.7 ± 43.3 35.7 ± 50.0 0.093
Median [IQR] 12.0 [4.0–48.0] 10.0 [4.0–48.0] 14.0 [4.0–48.0] 0.084
Tension-type headache (N = 863 [males 384; females 479])
Headache frequency (days/month)
Mean ± SD 1.8 ± 0.6 1.6 ± 1.9 2.0 ± 2.3 0.009
Median [IQR] 1.0 [0.3–2.0] 1.0 [0.2–2.0] 1.0 [0.3–3.0] 0.011
Headache intensity
Not bad 292 (33.8) 154 (40.1) 138 (28.8)
Quite bad 477 (53.3) 198 (51.6) 279 (58.2)
Very bad 94 (10.9) 32 (8.3) 62 (12.2)
Meanb ± SD 1.8 ± 0.6 1.7 ± 0.6 1.9 ± 0.6 <0.001
Medianb [IQR] 2 [1–3] 2 [1–2] 2 [1–2] <0.001
Headache duration
Mean ± SD 16.0 ± 31.0 14.0 ± 27.1 18.0 ± 33.6 0.043
Median [IQR] 4.0 [0.8–15.0] 4.0 [0.8–20.0] 4.0 [0.8–20.0] 0.030
Probable medication-overuse headache (N = 46 [males 11; females 35])
Headache frequency (days/month)
Mean ± SD 23.1 ± 6.2 19.4 ± 4.4 24.0 ± 6.3 0.010
Median [IQR] 20.0 [16.7–30.0] 17.0 [16.0–20.0] 30.0 [19.0–30.0] 0.063
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686 [38.2 %] rural; 949 [52.9 %] living at altitude ≥1000 m).
These 1794 were included in the analysis of burden;
728 [40.5 %] reported migraine, 863 [48.1 %] TTH,
46 [2.6 %] pMOH and 115 [6.4 %] other headache
on ≥15 days/month.
Symptom burden
Symptom burden is presented in Table 1 by headache
type and gender. From a public-health perspective it was
substantial: the mean overall reported headache fre-
quency was 3.8 days/month – 1 day in every eight – and
mean overall reported intensity was 2.1. Half of all par-
ticipants with headache (901; 50.2 %) reported moderate
headache and another nearly one third (520; 29.0 %) re-
ported severe headache. By headache type, pMOH was
of course the most frequent headache; it was followed by
migraine, then TTH. The same rank order was seen for
both headache intensity and duration. On every meas-
ure, females were worse affected than males with regard
to all headache and TTH, but not significantly so with
regard to migraine or (taking both means and medians
into account) pMOH.
Quality of life and willingness to pay
Participants without headache had significantly higher
(ie, better) WHOQOL-8 scores than those with headache
(median 29.0 [IQR: 27.0–31.0] vs 28.0 [25.0–30]; p <
0.001). WHOQOL-8 scores differed significantly between
headache types (p < 0.001), being lowest among people
with pMOH closely followed by those with migraine
(Table 2). However, WHOQOL scores were negatively
associated with frequency and intensity of headache (both
p < 0.001); accordingly, among participants with headache,
QoL was best in those with TTH (Table 2).
Participants with headache were willing to pay on aver-
age NPR 1134 ± 2760 (median 250 [IQR: 100–1000]) per
month for effective headache care. WTP differed signifi-
cantly (p = 0.013) between headache types, being highest
among those with pMOH. WTP was positively associated
Table 1 Symptom burden: frequency, intensity and duration of headache for all headache and each headache type, by gender
(Continued)
Headache intensity
Not bad 1 (2.2) 0 (0.0) 1 (2.9)
Quite bad 15 (32.6) 6 (54.5) 9 (25.7)
Very bad 30 (65.2) 5 (45.5) 25 (71.4)
Meanb ± SD 2.6 ± 0.5 2.5 ± 0.5 2.7 ± 0.5 0.65
Medianb [IQR] 3 [2–3] 2 [2–3] 3 [2–3] 0.23
Headache duration
Mean ± SD 318.9 ± 309.6 91.0 ± 82.8 390.5 ± 320.6 0.21
Median [IQR] 176.0 [40.0–720.0] 48.0 [32.0–200.0] 375.0 [45.0–720.0] 0.020
Values (if not otherwise stated) are n (%); SD standard deviation, IQR interquartile range; acomparing genders using Student’s t-test for difference between means
and Mann–Whitney U-test for medians; bmean and median on a scale of 0–3
Table 2 Quality of life (WHOQOL-8 score) and willingness to pay according to headache type, frequency and intensity
WHOQOL-8 score Willingness to pay (NPR/month)
Mean ± SD Median [IQR] pa Mean ± SD Median [IQR] pa
Headache type
Migraine 26.7 ± 3.9 27.0 [24.0–29.0] <0.001 1144 ± 2755 250 [100–250] 0.013
Tension-type headache 28.2 ± 3.7 28.0 [26.0–30.0] 1074 ± 2673 200 [60–200]
Probable medication-overuse headache 25.7 ± 4.2 26.0 [23.0–29.0] 2031 ± 3960 500 [150–2000]
Headache frequency (days/month)
1–3 27.7 ± 3.9 28.0 [25.0–30.0] <0.001 1056 ± 2760 200 [80–800] <0.001
4–14 26.8 ± 3.7 27.0 (24.0–27.0) 1301 ± 2273 300 [150–1500)
≥ 15 25.8 ± 4.0 26.0 (23.0–26.0) 1493 ± 3428 300 [150–1050)
Headache intensity
Not bad 28.7 ± 4.0 29.0 [26.0–32.0] <0.001 1252 ± 4084 200 [50–900] <0.001
Quite bad 27.6 ± 3.5 28.0 [26.0–30.0] 977 ± 2013 250 [100–800]
Very bad 26.1 ± 4.1 26.0 [23.0–29.0] 1.322 ± 2690 300 [110–1200]
IQR interquartile range, NPR Nepalese rupee; aKruskal-Wallis test
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with both frequency and intensity of headache (p < 0.001),
and therefore least in TTH (Table 2).
Disability
Among the 728 participants with migraine, 289 reported
attacks of ≥24 h’ duration, with a mean of 57.1 h (D1)
and a headache frequency of 2.38 days/month (HF1)
(Table 3). Using the formula AF =HF/D (see Methods),
we calculated AF for this group as AF1 = 2.38/(57.1/24),
which we took to be 1. Among the 46 with pMOH, 17
reported headache that “never goes away”. We took their
attack frequency (AF1) as 30, and duration (D1) as 24.
All other calculations of disability are explained in the
Methods section and set out in Table 3.
Mean DISper for migraine was 2.4 %; DISpop was
0.81 %. The corresponding values for TTH were sub-
stantially lower (0.15 and 0.06 %). For pMOH, however,
DISper was very much higher, at 9.7 %, while DISpop was
only 0.20 % because of the low prevalence.
Headache-attributed lost time
Headache-attributed lost time in the preceding 3 months
is presented by headache type in Table 4. All summed
scores (total lost productive time, lost paid worktime
and lost household worktime) had much higher means
for pMOH than for migraine, which itself had means
more than double those of TTH. However, it should be
noted that, for all five individual items and all headache
types, including pMOH, most medians were zero; this
meant not only that distributions were very highly
skewed, but also that at least half of respondents in most
groups lost no time at all.
More household worktime (2.7 ± 5.9 days) was lost
than paid worktime (1.7 ± 5.1 days), this difference being
largely but not entirely attributable to migraine (Table 4).
Regardless of headache type, males lost more paid work-
time than females and the reverse was the case with
household worktime.
From policy and economic perspectives, attention
might focus on total lost productive time (4.4 days in
3 months) from all headache, since this was the mean
loss for 85.4 % of the population. Assuming there were
13*5 working days in 3 months, this was a loss of 6.8 %
for those affected, or 5.8 % for the population generally.
However, 5.4 days lost in 3 months represented an 8.3 %
individual loss for those with migraine. As they were
34.1 % of the population [14], this was a 2.8 % loss for
the population generally.
Discussion
This is the first nationwide population-based survey to
estimate the burden of headaches disorders in Nepal, or
in any country within the South-East Asia Region. The
survey covered the whole country, recruiting a large rep-
resentative sample through careful random selection and
minimizing participation bias by achieving a very high
participation rate (>99 %).
As is the case elsewhere in the world, we found bur-
den levels were high in Nepal, on both individual and
population levels. The symptom burden was itself large,
Table 3 Population-level disability (adults aged 18–65 years), by headache type
Migraine Tension-type headache Probable medication-overuse
headache
n = 728




n = 863 n= 46
“never goes away”:
n = 17;
other: n = 29
Reported mean headache frequency [HF] (d/m) 2.3 (HF1 = 2.38, HF2 = 2.27) 1.8 23.1 (HF1 = 30, HF2 = 19.1)
Reported mean attack duration [D] (h) 33.6 (D1 = 57.1, D2 = 12.2) 16.0 12.1 (D1 = 24.0, D2 = 5.04)
Mean attack frequency [AF] (per month) (see text
for explanation)
AF1 = 1, AF2 = 2.27 1.8 AF1 = 30, AF2 = 19.1
Mean absolute time in ictal state [Tabs = AF*D] (h/m) Weighted mean of AF1*D1
and AF2*D2 = 39.36
AF*D = 28.8 Weighted mean of AF1*D1 and
AF2*D2 = 326.8
Mean time in ictal state as proportion of total
time Tpro = (Tabs*12)/(365*24)] (%)
5.4 3.9 44.7
Disability weight [DW] (from GBD 2013 [3] 0.441 0.037 0.217
Mean disability per person with headache
DISper = Tpro*DW] (%)
2.4 0.15 9.7
Prevalence in adults aged 18–65 years [P] (%) 34.1 41.5 2.1
Disability in population [DISpop = DISper * P] (%) 0.81 0.06 0.20
For migraine, HF1, D1 and AF1 refer to those with attacks of ≥24 h’ duration, HF2, D2 and AF2 to those with attacks of <24 h’ duration; for probable medication-overuse
headache, HF1, D1 and AF1 refer to those who report headache that never goes away, HF2, D2 and AF2 to those with headache of determinable duration; D days,
m month, h hours
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carried by females more than males. On all measures,
migraine imposed the greatest burden at population
level while pMOH did so on affected individuals. This
was reflected in impact on QoL. Participants with mi-
graine spent, on average, 5.4 % of their time (equivalent
to 20 days/year) in the ictal state, with headache of mean
intensity 2.3, which would certainly be disabling. How-
ever, this 5.4 % is less than the 8.3 % lost productive time
attributed to migraine, which says something about the
relationship between these. Lost paid worktime was
higher among males than females, but the reverse was
true of lost household worktime.
Headache-attributed lost productive time is a well-
validated measure of headache burden [17, 23, 25], yet it
is not clear exactly what its determinants may be. It re-
flects not so much disability as behavioural response to
impairment since, except in extreme cases, there is a de-
gree of choice in either continuing or abandoning work
when affected by headache [17]. In India, time spent by
those with migraine in the ictal state (4.2 %) was also
lower than the proportion of lost productive time
(5.8 %) [26]. Rao et al. observed that it is in the nature of
migraine that motivation and energy are lost, and that
these symptoms, likely also to contribute to lost prod-
uctivity, may for some time outlast what is described as
the ictal state [26]. Additionally, our method of calculat-
ing time in ictal state for migraine was perhaps conser-
vative in cases when attack duration was >24 h. In
calculating lost productive time our assumption might
also be questioned that there were only 65 working days
in 3 months, especially for household work, but on the
other hand this made no allowance for “holiday” time. It
has also to be said that the high symptom burden of mi-
graine in Nepal was not reflected in lost productive time
to the extent that might be anticipated: lost paid and
household worktime were both lower than in China
[27], Georgia [28] and Zambia [8], although higher than
in India [26] and much the same as in Russia [29].
In Nepal there are particular considerations that may
be relevant. The proportion of people in paid employ-
ment is very low [13, 30]. This is especially true for
women, who are predominantly engaged in agriculture;
few have skilled manual jobs, and they are much less
likely than men to be employed in professional, technical
or managerial fields [30]. The work of many women in
Nepal requires carriage of heavy loads by tumpline,
weight-bearing on head and neck – not easy with any
type of headache. Further, our enquiry might not have
been clear that time spent, for example, in producing
goods for home consumption, such as growing
Table 4 Headache-attributed lost time in preceding 3 months for all headache and each headache type, by gender
Total lost productive time Lost paid worktime Lost household worktime Missed social and leisure activities
Mean ± SD Median [IQR] Mean ± SD Median [IQR] Mean ± SD Median [IQR] Mean ± SD Median [IQR]
All headache
all (n = 1794) 4.4 ± 9.2 1 [0–5] 1.7 ± 5.1 0 [0–0] 2.7 ± 5.9 0 [0–3] 0.5 ± 2.8 0 [0–0]
male (n = 689) 4.5 ± 9.6 0 [0–5] 2.5 ± 5.6 0 [0–3] 2.0 ± 5.9 0 [0–2] 0.7 ± 4.1 0 [0–0]
female (n =1105) 4.4 ± 9.0 1 [0–5] 1.2 ± 4.8 0 [0–0] 3.2 ± 5.9 0 [0–4] 0.4 ± 1.4 0 [0–0]
pa 0.91 0.034 <0.001 <0.001 <0.001 <0.001 0.046 0.10
Migraine
all (n = 728) 5.4 ± 8.9 3 [0–7] 1.9 ± 4.6 0 [0–1] 3.5 ± 6.5 1 [0–5] 0.8 ± 4.1 0 [0–0]
male (n = 249) 7.1 ± 12.0 3 [0–9] 3.7 ± 6.3 0 [0–5] 3.4 ± 8.8 0 [0–3] 1.3 ± 6.5 0 [0–1]
female (n = 479) 4.5 ± 6.6 2 [0–6] 0.9 ± 3.0 0 [0–0] 3.5 ± 5.2 1 [0–5] 0.5 ± 1.7 0 [0–0]
pa 0.001 0.023 <0.001 <0.001 0.89 0.002 0.039 0.002
Tension-type headache
all (n = 863) 2.2 ± 4.7 0 [0–3] 0.9 ± 3.1 0 [0–0] 1.3 ± 2.8 0 [0–1] 0.2 ± 0.9 0 [0–0]
male (n = 384) 2.0 ± 5.0 0 [0–2] 1.2 ± 3.6 0 [0–1] 0.8 ± 2.1 0 [0–0] 0.2 ± 0.8 0 [0–0]
female (n = 479) 2.3 ± 4.3 0 [0–2] 0.7 ± 2.5 0 [0–0] 1.6 ± 3.2 0 [0–2] 0.2 ± 0.9 0 [0–0]
pa 0.31 0.009 0.010 <0.001 <0.001 <0.001 0.76 0.94
Probable medication-overuse headache
all (n = 46) 16.9 ± 25.9 6.5 [0–25.5] 8.0 ± 16.4 0 [0–6.2] 8.9 ± 13.6 0.5 [0–15] 1.2 ± 2.9 0 [0–7.3]
male (n = 11) 13.1 ± 14.7 7 [0–24] 10.2 ± 15.6 3 [0–24] 2.9 ± 6.2 0 [0–10] 2.8 ± 5.0 0 [0–2]
female (n = 35) 18.1 ± 28.1 6 [0–27] 7.3 ± 16.9 0 [0–5] 10.9 ± 14.7 5 [0–17] 0.7 ± 1.6 0 [0–0]
pa 0.44 0.87 0.60 0.23 0.015 0.089 0.18 0.17
SD standard deviation, IQR interquartile range; ap was estimated using Student’s t-test for differences between means and Mann–Whitney U-test for medians
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vegetables, should have counted in the context of the
Nepalese economy as paid (“income”-generating) rather
than household work. Therefore it is likely that lost pro-
ductive worktime was underestimated, especially among
women. The finding of greater lost productivity among
males than females should be interpreted with caution
in view of this and since the symptom burden was actu-
ally higher among females.
At population level, migraine caused most disability
(0.81 %). We might compare this with 0.46 % in neigh-
bouring India, where the survey used very similar
methods but was conducted only in the southern State
of Karnataka [26]. The difference approximately reflects
the lower prevalence of migraine in India (25.2 %) [9].
The 0.81 % implies a reduction by this amount of popu-
lation functional capacity. Whereas above we noted a
1.5-fold discrepancy between time spent in the ictal state
of migraine and lost productive time, here there is much
greater disparity: at population level, lost productive
time due to migraine was 2.8 %, or 3.5 times the disability.
Very similar disparities were found in India (3.3 times)
[26] and in Zambia (also 3.3 times, despite a higher dis-
ability of 0.98 %) [8]. The determinants of lost productive
time due to migraine may be unclear and probably com-
plex, but we see evidence here, nonetheless, of constancy
in its relationship to disability, which survives the influ-
ences of different behaviours among peoples from differ-
ent cultures.
Information on WTP can, in theory, be used to esti-
mate reasonable pricings and make economic forecasts
before introducing new health-care services [31, 32]. We
doubt its reliability for this purpose when gathered in
surveys of this type, but see it more as a measure of
overall burden [17]. As judged from the median WTP
(in view of the skewed distribution), participants with
headache were willing to pay NPR 250 (USD 2.50) per
month for effective headache care, the amount correlat-
ing with headache type (pMOH >migraine > TTH), fre-
quency and intensity. The absolute monetary value of
this might be lower than has been reported from other,
even low-income countries [28] but, put into local con-
text, it would be a day’s earnings for an average Nepalese
citizen [33]. As a measure of burden, this suggests heavy
burden. As a reflection of what people with headache
might be willing to invest in headache services, it signals
need but probably not sufficient willingness (or ability)
to pay.
Like all cross-sectional surveys, this study had limita-
tions. Most importantly it relied on retrospective en-
quiry over 3 months, and therefore participants’ recall,
to estimate impact of headache on work absence and
productivity. The effect of recall error is uncertain, but
it is more likely to have introduced random degrees of
over- and underestimation than systematic error [24].
We focused on the most bothersome headache type in
participants identifying more than one. In fact this
avoided double-counting: although it might be possible
in such a survey to diagnose multiple headache types,
correctly attributing burden between them is not a realis-
tic proposition. Among those with both migraine and
TTH, the former would usually be the more bothersome
[34]; this meant that some part of the burden of TTH was
instead attributed to migraine, but from a public-health
perspective this would have little consequence.
Implications for Nepal
Headache disorders are not only common in Nepal but
also highly burdensome: symptom burden is heavy, there
is much consequential disability and substantial lost prod-
uctivity. The economic cost is certain to be high. The rem-
edy lies in better health care for headache; structured
headache-care services are urgently needed in the country.
However, Nepal is among the least developed countries in
the world, with uneven distribution of its limited re-
sources [11]. Government allocation to the health sector
is also scarce; gaps in specialized health care exist at all
levels [35]. Furthermore, Nepal’s rural hilly/mountainous
geography poses great challenges to community health
services. Creating new headache-care services would cer-
tainly demand investment of additional financial and hu-
man resources in the health sector; on the other hand,
refraining from doing so will leave undiminished the bur-
den of these highly prevalent but cost-effectively treatable
brain disorders [36]. Structured headache services based
in primary care [37] would be an efficient, effective, af-
fordable and equitable model for Nepal, likely to be cost-
saving [4]. Such services, appropriately adapted, could be
implemented within the existing health-service structure
of Nepal. This potential solution requires further research
in order to inform political decision-makers. Doing noth-
ing is almost certainly a more costly option.
Conclusions
Headache disorders, very common in Nepal, are also
highly burdensome at both individual and population
levels. They cause disability and reduced functional cap-
acity, with a substantial penalty in lost production. The
remedy lies in better health care for headache; struc-
tured headache-care services are urgently needed in the
country, and likely to be cost-saving.
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